À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ºÍ²³½¡½ñÈÕÐû²¼£¬Öйú¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾Ö½«ÉúÎïÖÆÆ·ÉÏÊÐÉêÇëÂØ¿¨Ä¹£¨lecanemab£¬Ó¢ÎÄÉÌÆ·Ãû£ºLEQEMBI?£©ÄÉÈëÓÅÏÈÉóÆÀ£¬ÕâÊÇÒ»ÖÖ¿¹µí·ÛÑùÂÑ°× (A¦Â) Ô­ÏËά¿¹Ìå¡£¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾Ö½«Æô¶¯ÓÅÏÈÉóÆÀºÍÅú×¼·¨Ê½£¬Ö¼ÔÚ¼Ó¿ì¾ßÓÐÖØ´óÁÙ´²¼ÛÖµµÄÐÂÒ©µÄÑз¢ºÍÉÏÊС£Æ¾¾Ý¸Ã·¨Ê½£¬Ô¤¼Æ½«Ëõ¶ÌÉóÆÀʱ¼ä¡£

ÔÚÖйú£¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÓÚ2022Äê12ÔÂÏò¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾ÖÌá½»ÉÏÊÐÉêÇë²¢½«Æ¾¾Ý¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾ÖÒªÇóÔö²¹Ïà¹ØÊý¾Ý¡£

ÂØ¿¨Ä¹Ñ¡ÔñÐԵؽáºÏ²¢Çå³ý¿ÉÈܵġ¢¾ßÓÐÉñ¾­¶¾ÐÔµÄA¦Â¾Û¼¯Ì壨ԭÏËά£©¡£Òò´Ë£¬ÂØ¿¨Ä¹½«»á¶ÔADµÄ²¡ÀíÉúÀíѧ·¢ÉúÓ°Ï죬²¢¼õ»º¼²²¡µÄ½øÕ¹¡£Clarity ADÑо¿ÏÔʾ£¬ÂØ¿¨Ä¹µÄÖÎÁƵ½´ïÁËÖ÷ÒªÖÕµãºÍËùÓÐÒªº¦µÄ´ÎÒªÖյ㣬½á¹û¾ßÓÐÏÔÖøͳ¼ÆѧÒâÒå¡£2022Äê11Ô£¬Clarity AD Ñо¿µÄ½á¹ûÔÚ2022Äê°¢¶û´Äº£Ä¬²¡ÁÙ´²ÊÔÑ飨CTAD£©»áÒéÉÏÐû²¼£¬²¢Í¬Ê±·¢±íÔÚÊÀ½çÖøÃûµÄͬÐÐÆÀÉóҽѧÔÓÖ¾¡¶ÐÂÓ¢¸ñÀ¼Ò½Ñ§ÔÓÖ¾¡·ÉÏ¡£

ÔÚÃÀ¹ú£¬ÂØ¿¨Ä¹ÓÚ2023Äê1ÔÂ6ÈÕ»ñµÃÃÀ¹úʳƷºÍÒ©Îï¹ÜÀí¾Ö£¨FDA£©¼ÓËÙÅú×¼¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÔÚͬһÌìÌá½»ÁËÒ»·ÝÔö²¹ÉúÎïÖÆÆ·Ðí¿ÉÉêÇ루sBLA£©£¬ÒÔÖ§³ÖתΪ´«Í³Åú×¼¡£ÔÚÅ·ÖÞ£¬2023Äê1ÔÂ9ÈÕÏòÅ·ÖÞÒ©Æ·¹ÜÀí¾Ö£¨EMA£©Ìá½»ÁËÂØ¿¨Ä¹µÄÉÏÊÐÐí¿ÉÉêÇ루MAA£©²¢ÓÚ1ÔÂ26ÈÕ»ñµÃÊÜÀí¡£ÔÚÈÕ±¾£¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÓÚ2023Äê1ÔÂ16ÈÕÏòÒ©Æ·ºÍÒ½ÁÆÆ÷е¹ÜÀí¾Ö£¨PMDA£©Ìá½»ÉÏÊÐÐí¿ÉÉêÇ룬²¢ÓÚ2023Äê1ÔÂ26ÈÕ»ñµÃºñÉúÊ¡ÓÅÏÈÉóÆÀ×ʸñ¡£

ÂØ¿¨Ä¹µÄÈ«Çò¿ª·¢ºÍ¼à¹ÜÌá½»ÓÉÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Ö÷µ¼£¬¶ø²úÎïÔòÓÉÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ºÍ²³½¡ÅäºÏÉÌÒµ»¯ºÍÍƹ㣬ÆäÖÐÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÓµÓÐ×îÖÕ¾ö²ßȨ¡£

 

Contacts
MEDIA CONTACT: Eisai Co., Ltd. Public Relations Department TEL: +81-(0)3-3817-5120     INVESTOR CONTACT: Eisai Co., Ltd. Investor Relations Department TEL: +81-(0)3-3817-5122	MEDIA CONTACT: Biogen Inc. Natacha Gassenbach + 1-857-777-6573 public.affairs@biogen.com   INVESTOR CONTACT: Biogen Inc. Mike Hencke + 1-781-464-2442 IR@biogen.com